CONSOLIDATED | THE COMPANY | ||||
R million | Notes | 2007 | 2006 | 2007 | 2006 |
Cash flows operating activities | |||||
Consolidated profit before taxation | 1 527 | 5 103 | 3 356 | 4 188 | |
Adjustments | 23.1 | 309 | (3 588) | (3 358) | (4 191) |
Consolidatedprofit/(loss) before working capital | |||||
changes | 1 836 | 1 515 | (2) | (3) | |
Working capital changes | 23.2 | (170) | (41) | 2 | (2) |
Cash generated/(utilised) from operations | 1 666 | 1 474 | | (5) | |
Cash flow generated from returns on investments | 3 070 | 4 229 | 3 358 | 4 191 | |
Interest received | 334 | 341 | | | |
Dividends received | 23.3 | 2 736 | 3 888 | 3 358 | 4 191 |
Finance cost | (30) | (29) | | | |
Taxation paid | 23.4 | (676) | (369) | | |
Cash available from operating activities | 4 030 | 5 305 | 3 358 | 4 186 | |
Dividends paid | 23.5 | (3 813) | (4 676) | (3 782) | (4 860) |
Cash inflow/(outflow) from operating activities | 217 | 629 | (424) | (674) | |
Cash flows investing activities | |||||
Net investments to maintain operations | (109) | (54) | | | |
Replacement of property, plant and equipment | (124) | (83) | | | |
Proceeds on disposal of property, plant and equipment | 15 | 29 | | | |
Investments to expand operations | (673) | (1 362) | | | |
Additions to property, plant and equipment and other assets | (410) | (607) | | | |
investments and loans | (249) | (609) | | | |
Business acquired | (14) | (146) | | | |
Proceeds from disposal of investments and loans | 260 | 6 585 | | | |
Medi-Clinics cash transferred to associated company | | (879) | | | |
Purchase of treasury shares | (1 203) | (926) | | | |
Net cash generated/(utilised) before financing activities | (1 508) | 3 993 | (424) | (674) | |
Cash flows financing activities | 70 | 99 | 424 | 674 | |
(Increase)/decrease in loans | 40 | 93 | 424 | 5 209 | |
Issue of new shares by subsidiary companies | 12 | 10 | | | |
Capital contributed by minorities of subsidiary company | 18 | 7 | | | |
Shares cancelled | | (11) | | (4 535) | |
Net increase/(decrease) in cash and cash equivalents | (1 438) | 4 092 | | | |
Cash and cash equivalents at the beginning of the year | 6 339 | 2 247 | | | |
Cash and cash equivalents at the end of the year | 4 901 | 6 339 | | | |
Cash and cash equivalents per balance sheet | 5 004 | 6 357 | |||
Bank overdraft | (103) | (18) | |||